{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:19:53Z","timestamp":1778077193944,"version":"3.51.4"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,27]]},"abstract":"<jats:p>The optimal alteplase dose for bridging therapy in atrial fibrillation related large vessel occlusion stroke is uncertain. We compared low-dose alteplase plus mechanical thrombectomy with standard-dose bridging and direct thrombectomy. This single-center retrospective cohort included all consecutive eligible patients (n\u2005=\u2005375) treated between January 2021 and December 2024; no a priori sample size calculation was performed. Patients received low-dose alteplase 0.6\u2009mg\/kg plus thrombectomy (group A, n\u2005=\u2005120), standard-dose 0.9\u2009mg\/kg plus thrombectomy (group B, n\u2005=\u2005125), or direct thrombectomy without thrombolysis (group C, n\u2005=\u2005130). Primary outcomes were successful reperfusion (mTICI 2b\u20133), 90-day functional independence (mRS 0\u20132), and symptomatic intracerebral hemorrhage. Secondary outcomes included early neurologic change, 72 hour National Institutes of Health Stroke Scale, mortality, and key procedural metrics. Multivariable logistic regression adjusted for age, severity, time metrics, occlusion site, and comorbidities. Baseline features were similar. Versus direct thrombectomy, low-dose bridging improved reperfusion (91.7% vs 84.6) and increased 90-day independence (58.3% vs 45.4). Early improvement and 72 hour National Institutes of Health Stroke Scale favored low-dose bridging. Symptomatic intracerebral hemorrhage was lower with low-dose versus standard-dose bridging (3.3% vs 6.4) and comparable to direct thrombectomy. Low-dose bridging also shortened puncture-to-reperfusion time. In adjusted models, low-dose bridging predicted 90 day independence (odds ratio 1.68) and lower odds of symptomatic hemorrhage than standard-dose (odds ratio 0.48). Low-dose alteplase bridging before thrombectomy improved efficacy and safety in atrial fibrillation related large vessel occlusion stroke and may be preferable for patients at higher bleeding risk.<\/jats:p>","DOI":"10.1097\/md.0000000000048034","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:01:40Z","timestamp":1774630900000},"page":"e48034","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Impact of low-dose alteplase bridging therapy on outcomes after mechanical thrombectomy in patients with atrial fibrillation-associated acute stroke: A retrospective cohort study"],"prefix":"10.1097","volume":"105","author":[{"given":"Lianjun","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, People\u2019s Hospital of Baoji, Baoji, Shaanxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, People\u2019s Hospital of Baoji, Baoji, Shaanxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Neurology, People\u2019s Hospital of Baoji, Baoji, Shaanxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9950-0143","authenticated-orcid":false,"given":"Zhangyong","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Interventional, People\u2019s Hospital of Baoji, Baoji, Shaanxi Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260506","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"20","author":"Feigin","year":"2021","journal-title":"Lancet Neurol"},{"key":"R2-20260506","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"R3-20260506","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1136\/neurintsurg-2018-014569","article-title":"European Stroke Organisation (ESO) - European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke.","volume":"15","author":"Turc","year":"2023","journal-title":"J Neurointerv Surg"},{"key":"R4-20260506","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/neurintsurg-2020-015807","article-title":"MeVO: the next frontier?","volume":"12","author":"Goyal","year":"2020","journal-title":"J Neurointerv Surg"},{"key":"R5-20260506","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"R6-20260506","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jnnp.2004.048827","article-title":"Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke.","volume":"76","author":"Kimura","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R7-20260506","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1161\/STROKEAHA.117.016590","article-title":"Ischemic stroke: what does the histological composition tell us about the origin of the thrombus?","volume":"48","author":"Sporns","year":"2017","journal-title":"Stroke"},{"key":"R8-20260506","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12975-019-00735-6","article-title":"Complex clearance mechanisms after intraventricular hemorrhage and rt-PA treatment-a review on clinical trials.","volume":"11","author":"Bosche","year":"2020","journal-title":"Transl Stroke Res"},{"key":"R9-20260506","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/STROKEAHA.117.019261","article-title":"Successful reperfusion with intravenous thrombolysis preceding mechanical thrombectomy in large-vessel occlusions.","volume":"49","author":"Tsivgoulis","year":"2018","journal-title":"Stroke"},{"key":"R10-20260506","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1161\/STROKEAHA.114.005245","article-title":"Different doses of recombinant tissue-type plasminogen activator for acute stroke in Chinese patients.","volume":"45","author":"Chao","year":"2014","journal-title":"Stroke"},{"key":"R11-20260506","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1161\/STROKEAHA.109.562991","article-title":"Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients: general outcomes and prognostic factors from the SAMURAI register.","volume":"40","author":"Toyoda","year":"2009","journal-title":"Stroke"},{"key":"R12-20260506","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/jamaneurol.2017.2286","article-title":"Low-dose vs standard-dose alteplase for patients with acute ischemic stroke: secondary analysis of the ENCHANTED randomized clinical trial.","volume":"74","author":"Wang","year":"2017","journal-title":"JAMA Neurol"},{"key":"R13-20260506","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa1515510","article-title":"Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke.","volume":"374","author":"Anderson","year":"2016","journal-title":"N Engl J Med"},{"key":"R14-20260506","first-page":"666","article-title":"Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018.","volume":"51","year":"2018","journal-title":"Chin J Neurol"},{"key":"R15-20260506","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/1747493019840932","article-title":"The randomized study of endovascular therapy with versus without intravenous tissue plasminogen activator in acute stroke with ICA and M1 occlusion (SKIP study).","volume":"14","author":"Suzuki","year":"2019","journal-title":"Int J Stroke"},{"key":"R16-20260506","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/STROKEAHA.117.018427","article-title":"STARTING-SICH nomogram to predict symptomatic intracerebral hemorrhage after intravenous thrombolysis for stroke.","volume":"49","author":"Cappellari","year":"2018","journal-title":"Stroke"},{"key":"R17-20260506","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet (London, England)"},{"key":"R18-20260506","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2001123","article-title":"Endovascular thrombectomy with or without intravenous alteplase in acute stroke.","volume":"382","author":"Yang","year":"2020","journal-title":"N Engl J Med"},{"key":"R19-20260506","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJMoa2107727","article-title":"A randomized trial of intravenous alteplase before endovascular treatment for stroke.","volume":"385","author":"LeCouffe","year":"2021","journal-title":"N Engl J Med"},{"key":"R20-20260506","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S1474-4422(22)00519-1","article-title":"Thrombolysis for acute ischaemic stroke: current status and future perspectives.","volume":"22","author":"Tsivgoulis","year":"2023","journal-title":"Lancet Neurol"},{"key":"R21-20260506","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(22)00564-5","article-title":"Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4\u00b75\u2009h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial.","volume":"400","author":"Mitchell","year":"2022","journal-title":"Lancet (London, England)"},{"key":"R22-20260506","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/neurintsurg-2021-017726","article-title":"Predictors of poor outcome despite successful endovascular treatment for ischemic stroke: results from the MR CLEAN Registry.","volume":"14","author":"van de Graaf","year":"2022","journal-title":"J Neurointerv Surg"},{"key":"R23-20260506","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3174\/ajnr.A5829","article-title":"Balloon-guide catheters are needed for effective flow reversal during mechanical thrombectomy.","volume":"39","author":"Nikoubashman","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"R24-20260506","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1161\/STROKEAHA.116.014147","article-title":"Cost-effectiveness of endovascular stroke therapy: a patient subgroup analysis from a US healthcare perspective.","volume":"47","author":"Kunz","year":"2016","journal-title":"Stroke"},{"key":"R25-20260506","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(11)60325-5","article-title":"Stroke rehabilitation.","volume":"377","author":"Langhorne","year":"2011","journal-title":"Lancet (London, England)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:01:13Z","timestamp":1778076073000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":25,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048034","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"2025-11-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}